Sam Obgartel
Family Medicine · Luling, LANPI 1457769234
Payments from drug & device makers
Across 73 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$326
- Dexcom, Inc.$296
- Lilly USA, LLC$187
- Pfizer$137
- Johnson & Johnson$124
- Exact Sciences$92
- plus $626 from 14 others
What the payments were for
- Food & beverage$1,787100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $326 |
| Dexcom, Inc. | 6 | $296 |
| Lilly USA, LLC | 12 | $187 |
| Pfizer | 7 | $137 |
| Johnson & Johnson | 1 | $124 |
| Exact Sciences | 5 | $92 |
| AbbVie | 6 | $87 |
| Phadia US Inc. | 5 | $76 |
| Novo Nordisk | 5 | $74 |
| Boehringer Ingelheim | 4 | $71 |
| Merck | 4 | $61 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Abbott | 2 | $45 |
| Viiv Healthcare Company | 1 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Sanofi Pasteur Inc. | 1 | $21 |
| GSK | 1 | $19 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Gilead | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$228
- FARXIGA$125
- XARELTO$124
How this compares
$1,787 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $56,789 |
| FarxigaDapagliflozin Propanediol | 30 | $25,336 |
| JardianceEmpagliflozin | 13 | $18,124 |
| LinzessLinaclotide | 17 | $14,854 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 49 | $4,979 |
| Novolog FlexpenInsulin Aspart | 15 | $3,534 |
| Levemir FlexpenInsulin Detemir | 12 | $1,938 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 15 | $874 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 13 | $801 |
| Atorvastatin Calcium | 82 | $720 |
| Fluticasone Propionate | 55 | $562 |
| Metformin Hcl | 80 | $444 |
| Losartan Potassium | 48 | $386 |
| Hydroxyzine Hcl | 21 | $366 |
| Alendronate Sodium | 56 | $365 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $74 | $56,78956 claims |
| AstraZenecaFarxiga | $326 | $25,33630 claims |
| Boehringer IngelheimJardiance | $71 | $18,12413 claims |
| AbbVieLinzess | $87 | $14,85417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Luling
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
- Kristen ThomasNew Orleans$361K
- Clint WilsonBossier City$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.